Prevalence of gingival overgrowth in renal transplant recipients on sirolimus immunosuppressive therapy is not clearly established.
The authors attempted to study the gingival status of renal transplant patients receiving sirolimus immunosuppressive therapy by measuring the presence and severity of gingival overgrowth (GO) and by investigating the association between GO and sociodemographic, medical, and pharmacologic variables. Grants from the Coordination of Improvement of Upper Level Personnel (CAPES), Brasilia, DF, Brazil, and the Foundation for Support of Research in Minas Gerais (FAPEMIG/#13016). Cross-sectional Level 3: Other evidence. Not applicable.